An estimation of the worldwide economic and health burden of visual impairment

Abstract This study aims to provide a rigorous estimate of the worldwide costs of visual impairment (VI), and the associated health burden. The study used a prevalence-based model. Prevalence rates for mild VI (visual acuity (VA) worse than 6/12 but not worse than 6/18), moderate VI (VA worse than 6/18 but not worse than 6/60) and blindness (VA worse than 6/60) were applied to population forecasts for each World Health Organisation (WHO) subregion. The limited available country cost data were extrapolated between subregions using economic and population health indicators. Age and gender subgroup population numbers were derived from United Nations’ data. Costs and the health burden of VI were estimated for each world subregion using published disease prevalence rates, health care expenditures and other economic data. The study includes direct health care costs, indirect costs and the health burden of VI. The total cost of VI globally was estimated at $3 trillion in 2010, of which $2.3 trillion was direct health costs. This burden is projected to increase by approximately 20% by 2020. VI is associated with a considerable disease burden. Unless steps are taken to reduce prevalence through prevention and treatment, this burden will increase alongside global population growth.

[1]  J E Keeffe,et al.  The economic impact and cost of visual impairment in Australia , 2005, British Journal of Ophthalmology.

[2]  R. Bourne,et al.  Prevalence and causes of blindness and visual impairment in Bangladeshi adults: results of the National Blindness and Low Vision Survey of Bangladesh , 2003, The British journal of ophthalmology.

[3]  L. Dandona,et al.  Revision of visual impairment definitions in the International Statistical Classification of Diseases , 2006, BMC medicine.

[4]  Edgar K. Browning.  On the Marginal Welfare Cost of Taxation , 1987 .

[5]  Yingfeng Zheng,et al.  Prevalence and causes of visual impairment in Chinese adults in urban southern China. , 2009, Archives of ophthalmology.

[6]  M. Gold.  Cost-effectiveness in health and medicine , 2016 .

[7]  S. Resnikoff,et al.  Global data on visual impairment in the year 2002. , 2004, Bulletin of the World Health Organization.

[8]  J. J. Wang,et al.  Visual impairment, age-related cataract, and mortality. , 2001, Archives of ophthalmology.

[9]  Linus Jönsson,et al.  The worldwide societal costs of dementia: Estimates for 2009 , 2010, Alzheimer's & Dementia.

[10]  O Johnell,et al.  The socioeconomic burden of fractures: today and in the 21st century. , 1997, The American journal of medicine.

[11]  J. Keeffe,et al.  The cost of care for people with impaired vision in Australia. , 2009, Archives of ophthalmology.

[12]  Alan D. Lopez,et al.  The burden of disease and injury in Australia. , 2001, Bulletin of the World Health Organization.

[13]  J. Katz,et al.  Blindness and vision impairment in a rural south Indian population: the Aravind Comprehensive Eye Survey. , 2003, Ophthalmology.

[14]  R. Khandekar,et al.  Prevalence and Causes of Blindness & Low Vision; Before and Five Years After ‘VISION 2020’ Initiatives in Oman: A Review , 2007, Ophthalmic epidemiology.

[15]  Alan D. Lopez,et al.  The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .

[16]  Joshua A. Salomon,et al.  National burden of disease Studies: a practical guide. Global Program on Evidence for Health Policy , 2001 .

[17]  J. L. Hidalgo,et al.  Visual Function Versus Visual Acuity in Older People , 2009, Ophthalmic epidemiology.

[18]  J. Smith,et al.  The economic burden of global blindness: a price too high! , 1996, The British journal of ophthalmology.

[19]  Jan J. Barendregt,et al.  Disability weights for diseases in the Netherlands , 1997 .

[20]  Charles E. Stuart.  Welfare Costs per Dollar of Additional Tax Revenue in the United States , 1984 .

[21]  L. Ellwein,et al.  Prevalence and Causes of Vision Impairment and Blindness in Older Adults in Brazil: The São Paulo Eye Study , 2008, Ophthalmic epidemiology.

[22]  H. Limburg,et al.  Cataract blindness in Turkmenistan: results of a national survey , 2002, The British journal of ophthalmology.

[23]  E. Auriol,et al.  The Marginal Cost of Public Funds in Africa , 2005 .

[24]  Alan D. Lopez,et al.  Global burden of disease and risk factors , 2006 .

[25]  Productivity Commission.  Evaluation of the Pharmaceutical Industry Investment Program , 2003 .

[26]  B. Winblad,et al.  An Estimate of the Worldwide Prevalence and Direct Costs of Dementia in 2003 , 2006, Dementia and Geriatric Cognitive Disorders.

[27]  K. Naidoo,et al.  Potential lost productivity resulting from the global burden of uncorrected refractive error. , 2009, Bulletin of the World Health Organization.

[28]  Edgar K. Browning.  The Marginal Cost of Public Funds , 1976, Journal of Political Economy.

[29]  Y-Ct Shih,et al.  A Comparison of Costs of Informal Caregivers Between the Visually Impaired and Unimpaired Elderly in the US , 2002 .

[30]  H. Taylor,et al.  Vision impairment predicts 5 year mortality , 2001, The British journal of ophthalmology.

[31]  H. Taylor,et al.  The cost of visual impairment: purposes, perspectives, and guidance. , 2010, Investigative ophthalmology & visual science.

[32]  Emily W. Gower,et al.  Economic impact of visual impairment and blindness in the United States. , 2007, Archives of ophthalmology.

[33]  G. Murthy,et al.  Current estimates of blindness in India , 2005, British Journal of Ophthalmology.

[34]  H R Taylor,et al.  Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the Visual Impairment Project. , 2001, Ophthalmology.

[35]  R. Klein,et al.  Age-related eye disease and survival. The Beaver Dam Eye Study. , 1995, Archives of ophthalmology.

[36]  J. Hubschman,et al.  Age-related eye disease. , 2013, Maturitas.

[37]  T. Naduvilath,et al.  Prevalence and causes of blindness and low vision in Timor-Leste , 2007, British Journal of Ophthalmology.

[38]  Rakhi Dandona,et al.  What is the global burden of visual impairment? , 2006, BMC medicine.

[39]  H. Limburg,et al.  Cataract blindness in Chakwal District, Pakistan: Results of a survey , 2003, Ophthalmic epidemiology.

[40]  Nuno Lunet,et al.  Burden of Disease and Risk Factors , 2010 .

[41]  C. Murray,et al.  Understanding DALYs (disability-adjusted life years). , 1997, Journal of health economics.

[42]  J. Keeffe,et al.  Direct costs of blindness in Australia , 2000, Clinical & experimental ophthalmology.

[43]  J. Barendregt,et al.  Global burden of disease , 1997, The Lancet.

[44]  R. Klein,et al.  The economic burden of major adult visual disorders in the United States. , 2006, Archives of ophthalmology.

[45]  L. Ellwein,et al.  A population based eye survey of older adults in Tirunelveli district of south India: blindness, cataract surgery, and visual outcomes , 2002, The British journal of ophthalmology.

[46]  H. Limburg,et al.  Cataract blindness in 4 regions of Guatemala: results of a population-based survey. , 2007, Ophthalmology.

[47]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[48]  H. Limburg,et al.  Rapid Assessment of Visual Impairment Due to Cataract and Cataract Surgical Services in Urban Argentina , 2006, Ophthalmic epidemiology.

[49]  Rupert R A Bourne,et al.  Prevalence of blindness and visual impairment in Pakistan: the Pakistan National Blindness and Visual Impairment Survey. , 2006, Investigative ophthalmology & visual science.

[50]  Charles L. Ballard,et al.  General Equilibrium Computations of the Marginal Welfare Costs of Taxes in the United States , 1985 .

[51]  Allen Foster,et al.  The magnitude and cost of global blindness: an increasing problem that can be alleviated. , 2003, American journal of ophthalmology.

[52]  C. Hyde,et al.  What is the cost of blindness? , 2003, The British journal of ophthalmology.

[53]  H. Limburg,et al.  Cataract blindness in Paraguay – results of a national survey , 2003, Ophthalmic epidemiology.

[54]  M. Koopmanschap,et al.  Economic valuation of informal care: lessons from the application of the opportunity costs and proxy good methods. , 2006, Social science & medicine.

[55]  D. Usher.  The Marginal Cost of Public Funds Is the Ratio of Mean Income to Median Income , 2006 .

[56]  Serge Resnikoff,et al.  Global magnitude of visual impairment caused by uncorrected refractive errors in 2004. , 2008, Bulletin of the World Health Organization.

[57]  H. Kleven,et al.  The Marginal Cost of Public Funds: Hours of Work Versus Labor Force Participation , 2006 .